Dr. Jiaying Tan is the Head of Strategy and Partnership in Greater China at Cell Press, and a Senior Scientific Editor at Cell. She earned her PhD in Molecular and Cellular Pathology in the University of Michigan-Ann Arbor in 2012, before moving to the Novartis Institutes for BioMedical Research in Shanghai to conduct postdoctoral research in cancer biology. She joined the Cell editorial team in 2013. During the past few years, she has also served as a consulting editor at Cell Reports, the acting Editor-in-Chief of The Lancet Haematology from July 2018 to January 2019, and the co-acting Editor-in-Chief of Cancer Cell from October 2019 to February 2020.